Table 3.
Correlation between COMMD3 expression level and clinical-pathological variables in HCC patients
| Characteristics | High commd3 | Low commd3 | χ2 | P value |
|---|---|---|---|---|
| Age group/n (%) | 0.79 | 0.374 | ||
| < 60 years | 80 (43.0%) | 89 (47.6%) | ||
| ≥ 60 years | 106 (57.0%) | 98 (52.4%) | ||
| Gender/n (%) | 1.216 | 0.270 | ||
| Male | 131 (70.1%) | 121 (67.4%) | ||
| Female | 56 (29.9%) | 66 (32.6%) | ||
| Race/n (%) | 1.099 | 0.294 | ||
| White | 84 (47.2%) | 98 (52.7%) | ||
| Others | 94 (52.8%) | 88 (47.3%) | ||
| G stage/n (%) | 0.154 | 0.695 | ||
| G1+ G2 | 118 (64.1%) | 115 (62.2%) | ||
| G3+ G4 | 66 (35.9%) | 70 (37.8%) | ||
| TNM stage/n (%) | 5.728 | 0.017 | ||
| I+ II | 121 (68.4%) | 140 (79.5%) | ||
| III+ IV | 56 (31.6%) | 36 (20.5%) | ||
| T stage/n (%) | 4.747 | 0.029 | ||
| T1+T2 | 129 (69.7%) | 148 (79.6) | ||
| T3+T4 | 56 (30.3.9%) | 38 (20.4%) | ||
| Vascular invasion/n (%) | 10.111 | 0.001 | ||
| Yes | 65 (43.6%) | 45 (26.6%) | ||
| No | 84 (56.4%) | 124 (73.4%) |
HCC, hepatocellular carcinoma.